cancer gene analysis
The UKSCB requires an external contractor (third party) to perform cancer gene analysis on UKSCB derived EU Tissue and Cellular Directive (EUTCD) compliant human embryonic stem cell (hESC) lines. UKSCB is licenced under the HTA Human Tissue (Quality and Safety for Human Application) Regulations 2018 for the production of starting materials for clinical application. According to HTA regulations any testing activities that are subcontracted to external contractors must be appropriately validated to demonstrate that t...
Buyer
Medicines and Healthcare Products Regulatory Agency
Value
Not provided
Published
4 May 2018
Closes
4 May 2018
Procurement details
Source
Contracts Finder
Region
United Kingdom
Procurement method
Not provided
Category
Goods
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
33159000
Clinical chemistry system
Lots
Lot default cancer gene analysis
Value not provided
The UKSCB requires an external contractor (third party) to perform cancer gene analysis on UKSCB derived EU Tissue and Cellular Directive (EUTCD) compliant human embryonic stem cell (hESC) lines. UKSCB is licenced under the HTA Human Tissue (Quality and Safety for Human Application) Regulations 2018 for the production of starting materials for clinical appli...
Documents
Unlock document linkEarly engagement notice on Contracts Finder
4 May 2018
Early engagement notice on Contracts Finder
Market engagement notice · Web page
Contains public sector information licensed under the Open Government Licence v3.0.